All Search Results
News Releases
Jul 16, 2026, 02:55 ET GIMM Festival brings leading microbiology experts to Lisbon to discuss emerging viruses, antimicrobial resistance and biological engineering
antimicrobial resistance and bacterial evolution, emerging viruses and preparedness for future pandemics, as well as microorganism engineering and synthetic biology.Antimicrobial resistance is considered by the World Health Organization one of the greatest threats to global health, with the potential
More news about: Fundação GIMM - Gulbenkian Institute for Molecular Medicine
Jul 08, 2026, 10:17 ET Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026
About TsingkeTsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven
More news about: Beijing Tsingke Biotech Co., Ltd.
Jul 08, 2026, 10:17 ET Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026
characterization.About TsingkeTsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven
More news about: Beijing Tsingke Biotech Co., Ltd.
Jul 07, 2026, 10:01 ET Gene Editing Market to Reach US$30.5 Billion by 2033 as Precision Medicine and CRISPR Innovation Accelerate Growth - Persistence Market Research
Gene Switches, Repressible Gene Switches), Technology (CRISPR-based Systems, Zinc Finger Proteins (ZFP), Others), Application (Gene Therapy, Synthetic Biology, Others), and Regional Analysis for 2026 - 2033
More news about: Persistence Market Research Pvt. Ltd.
Jul 06, 2026, 08:55 ET As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
partnership or comparable performance.Absci (NASDAQ: ABSI) is a clinical-stage biopharmaceutical company that applies generative AI and synthetic biology to design antibody therapeutics, pairing AI models with high-throughput wet-lab validation. Absci illustrates the AI-native, model-plus-wet-lab
More news about: USA News Group
